Page 339 - ATP-P 11th Ed

®
• The Actiq unit should be consumed over a 15 minute period. Longer or shorter con-
sumption times may produce less efficacy than reported in Actiq clinical trials. If signs
®
of excessive opioid effects appear before the unit is consumed, the drug matrix should be
removed from the patient’s mouth immediately and future doses should be decreased.
K9 Dose: Place lozenge in rectum (can tape to tail) and monitor dog’s response closely.
Contraindications: Known allergy to medication
Pregnancy Category C
Treatment of overdose:
• Ventilatory support
• Intravenous access
®
• Naloxone (Narcan ) or another opioid antagonist may be warranted in some instances,
but it is associated with the risk of precipitating an acute withdrawal syndrome.
Side-effects:
• The most serious adverse effects associated with all opioids are:
° Respiratory depression (potentially leading to apnea or respiratory arrest)
° Circulatory depression
° Hypotension SECTION 3
° Shock
° All patients should be followed for symptoms of respiratory depression.
TMEP use:
• K9 Trauma Management Protocol
• Pain Management Protocol
®
Osmotrol – See Mannitol
®
Oxymetazline HCl (Afrin Nasal Spray)
Description: Vasoconstrictor (decongestant)
Indications: Use as an adjunct to valsalva maneuver to clear ears and sinuses during com-
pression and decompression.
Dose: Spray into each nostril 2 times, twice daily. Not to exceed three consecutive days due
to rebound congestion.
• Note: Do not tilt head backwards while spraying.
Contraindications: Severe damage to tympanic membrane/sinuses from barotrauma
Pregnancy Category C
Side-effects:
• Burning
• Sneezing and stinging of nasal mucosa
Adverse reactions:
• Rhinitis
• Rebound congestion

ATP-P Handbook 11th Edition 329